Tags

Type your tag names separated by a space and hit enter

Development of a stability-indicating CE assay for the determination of amlodipine enantiomers in commercial tablets.
Electrophoresis. 2008 Nov; 29(22):4583-92.E

Abstract

A simple, accurate, precise and sensitive method using CD for separation and stability indicating assay of enantiomers of amlodipine in the commercial tablets has been established. Several types of CD were evaluated and best results were obtained using a fused-silica capillary with phosphate running buffer (100 mM, pH 3.0) containing 5 mM hydroxypropyl-alpha-CD. The method has shown adequate separation for amlodipine enantiomers from its degradation products. The drug was subjected to oxidation, hydrolysis, photolysis and heat to apply stress conditions. The range of quantitation for both enantiomers was 5-150 microg/mL. Intra- and inter-day RSD (n=6) was <4%. The limit of quantification that produced the requisite precision and accuracy was found to be 5 microg/mL for both enantiomers. The LOD for both enantiomers was found to be 0.5 microg/mL. Degradation products produced as a result of stress studies did not interfere with the detection of enantiomers and the assay can thus be considered stability indicating.

Authors+Show Affiliations

Department of Chemistry, Faculty of Sciences, Shahid Beheshti University, Tehran, IR Iran. a-zavareh@sbu.ac.irNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18985664

Citation

Fakhari, Ali Reza, et al. "Development of a Stability-indicating CE Assay for the Determination of Amlodipine Enantiomers in Commercial Tablets." Electrophoresis, vol. 29, no. 22, 2008, pp. 4583-92.
Fakhari AR, Nojavan S, Haghgoo S, et al. Development of a stability-indicating CE assay for the determination of amlodipine enantiomers in commercial tablets. Electrophoresis. 2008;29(22):4583-92.
Fakhari, A. R., Nojavan, S., Haghgoo, S., & Mohammadi, A. (2008). Development of a stability-indicating CE assay for the determination of amlodipine enantiomers in commercial tablets. Electrophoresis, 29(22), 4583-92. https://doi.org/10.1002/elps.200800330
Fakhari AR, et al. Development of a Stability-indicating CE Assay for the Determination of Amlodipine Enantiomers in Commercial Tablets. Electrophoresis. 2008;29(22):4583-92. PubMed PMID: 18985664.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Development of a stability-indicating CE assay for the determination of amlodipine enantiomers in commercial tablets. AU - Fakhari,Ali Reza, AU - Nojavan,Saeed, AU - Haghgoo,Soheila, AU - Mohammadi,Ali, PY - 2008/11/6/pubmed PY - 2009/4/21/medline PY - 2008/11/6/entrez SP - 4583 EP - 92 JF - Electrophoresis JO - Electrophoresis VL - 29 IS - 22 N2 - A simple, accurate, precise and sensitive method using CD for separation and stability indicating assay of enantiomers of amlodipine in the commercial tablets has been established. Several types of CD were evaluated and best results were obtained using a fused-silica capillary with phosphate running buffer (100 mM, pH 3.0) containing 5 mM hydroxypropyl-alpha-CD. The method has shown adequate separation for amlodipine enantiomers from its degradation products. The drug was subjected to oxidation, hydrolysis, photolysis and heat to apply stress conditions. The range of quantitation for both enantiomers was 5-150 microg/mL. Intra- and inter-day RSD (n=6) was <4%. The limit of quantification that produced the requisite precision and accuracy was found to be 5 microg/mL for both enantiomers. The LOD for both enantiomers was found to be 0.5 microg/mL. Degradation products produced as a result of stress studies did not interfere with the detection of enantiomers and the assay can thus be considered stability indicating. SN - 1522-2683 UR - https://www.unboundmedicine.com/medline/citation/18985664/Development_of_a_stability_indicating_CE_assay_for_the_determination_of_amlodipine_enantiomers_in_commercial_tablets_ L2 - https://doi.org/10.1002/elps.200800330 DB - PRIME DP - Unbound Medicine ER -